Medimabs/HIV-1（CD4bs（gp120））人单克隆抗体（654-30D）/100µg/MM-0255-P
商品编号：
MM-0255-P
品牌：
Medimabs inc
市场价：
¥10100.00
美元价：
8080.00
产品分类：
单克隆抗体
公司分类：
monoclonal_antibody
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
Target:
HIV-1 (CD4bs (gp120))
Target background:
Of the two types of Human immunodeficiency virus (HIV) which have been characterized, HIV-1 is more infective and is prevalent globally. The HIV virion is encapsulated by a viral envelope that contains complexes of surface proteins including glycoprotein 120 (gp120), which are important for the virus to attach and fuse to infect target cells. The glycoprotein CD4 (cluster of differentiation 4), found on the surface of T-cells, interacts with gp120 and cytokine receptors to mediate the entry of the virus into cells. This antibody, 654-30D, has been shown to neutralize HIV-1.
Immunogen:
This antibody was generated from HIV-infected individuals by a method based on the Epstein-Barr virus transformation of peripheral blood mononuclear cells (PBMCs) followed by fusion with heteromyeloma cells. The epitope for this antibody is discontinuous.
Specificity: The antibody recognizes the CD4 binding domain of the HIV-1 protein gp120.
Clone ID:
654-30D
Isotype:
IgG1 lambda
Preservative:
None
Format:
Lyophilized protein G purified in PBS pH7.4
Recommend starting dilution:
Reconstitute with deionized water. Optimal dilution has to be determined by the user.
Limitations:
Research Use Only
References:
1.-Li L - Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject.
2.-Gorny MK - Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from...
3.-Jeffs SA - Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120.
4.-Gorny MK - Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins.
5.-Nyambi PN - Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.
6.-Gorny MK - A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.
7.-Nyambi PN - Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness ...
8.-Hioe CE - Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies.
9.-Gorny MK - Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.
10.-Stamatatos L - Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 in...
11.-Zolla-Pazner S - Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry.
12.-Laal S - Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies.
13.-Gorny MK - Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.
Storage:
Lyophilized antibodies can be kept at 4ºC for up to 3 months and should be kept at -20ºC for long-term storage (2 years). To avoid freeze-thaw cycles, reconstituted antibodies should be aliquoted before freezing for long-term (1 year) storage (-80ºC) or kept at 4ºC for short-term usage (2 months). For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made with the assay buffer. After the maximum long-term storage period (2 years lyophilized or 1 year reconstituted) antibodies should be tested in your assay with a standard sample to verify if you have noticed any decrease in their efficacy.
品牌介绍
Medimabs让我们的专家团队为您定制抗体的开发确定最佳方法：肽，蛋白质或DNA免疫。受益于他们的专业战略建议，可靠的抗原设计和快速合成抗体开发中最关键的一步是抗原策略和设计。为了使您的项目成功的机会最大化，我们将深入分析目标的结构，并找到最佳的选择以获得适合您的应用需求的抗体。整个项目可以根据您的最终应用进行定制（流式细胞仪，治疗，蛋白质印迹，免疫荧光，ELISA，免疫沉淀等）。我们可以获得广泛的免疫原，并且每种免疫原都有其优势。 合成肽蛋白质（细菌，酵母，昆虫或哺乳动物细胞表达模型） DNA免疫让我们指导您，为您的项目设计最佳抗原。
